A versatile metal–organic nanoplatform in combination with CXCR4 antagonist and PD-L1 inhibitor for multimodal synergistic cancer therapy and MRI-guided tumor imaging
Di Liu, Hongliang He, Fei Kong, Yixiang Cao, Fengchao Zang, Ming Ma, Ning Gu, Yu Zhang
Topics & Concepts
Tumor microenvironmentMetastasisCancer researchCXCR4CancerCancer cellCombination therapyMultimodal therapyImmunosuppressionCXCR4 antagonistChemistryPharmacologyMedicineReceptorImmunologyTumor cellsInternal medicineBiochemistryChemokineNanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryImmune cells in cancer